Printer Friendly

ROYCE LABORATORIES ANNOUNCES FILING OF SHAREHOLDER LAWSUITS

 ROYCE LABORATORIES ANNOUNCES FILING OF SHAREHOLDER LAWSUITS
 MIAMI, April 28 /PRNewswire/ -- Royce Laboratories, Inc. (NASDAQ: RLAB) today announced that several lawsuits have been filed against it, and certain of its officers and directors. The suits, which seek unspecified damages, principally allege violations of the federal securities laws and common law fraud. The lawsuits principally appear to allege that the company and its officers and directors knew or should have known that the company's Abbreviated New Drug Application for Piroxicam was not going to be approved by the Food and Drug Administration. The company, on behalf of itself and its officers and directors, denies this allegation.
 Patrick J. McEnany, the company's president, stated, "We believe these suits are without merit and we intend to vigorously defend them."
 Royce Laboratories, Inc. is a manufacturer of prescription and over the counter generic pharmaceuticals.
 -0- 4/28/92
 /CONTACT: Patrick J. McEnany, president of Royce Laboratories, Inc., 305-624-1500/
 (RLAB) CO: Royce Laboratories, Inc. ST: Florida IN: MTC SU:


AW-JJ -- FL007 -- 3800 04/28/92 12:26 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 28, 1992
Words:173
Previous Article:NORTHBAY FINANCIAL ANNOUNCES REVISIONS TO DIVIDEND AND PAYMENT DATES
Next Article:MICHIGAN NATIONAL'S EARNINGS FOR THE FIRST QUARTER 1992 IMPROVED FROM THE SAME PERIOD LAST YEAR


Related Articles
ROYCE LABORATORIES FILES FOR $6 MILLION SECONDARY PUBLIC OFFERING
ROYCE LABORATORIES VOLUNTARILY WITHDRAWS APPLICATIONS FOR MINOXIDIL
ROYCE LABORATORIES VOLUNTARILY WITHDRAWS APPLICATIONS FOR MINOXIDIL
ROYCE LABORATORIES ANNOUNCES FIRST QUARTER RESULTS
ROYCE LABORATORIES ANNOUNCES WITHDRAWAL OF ANDAs FOR HALOPERIDOL
ROYCE LABORATORIES, INC. ANNOUNCES YEAR-END RESULTS
ROYCE LABORATORIES, INC. ANNOUNCES YEAR-END RESULTS
ROYCE LABORATORIES, INC. ANNOUNCES THIRD QUARTER AND NINE MONTHS RESULTS
Royce Laboratories Announces Meeting Date for Special Meeting of Shareholders To Consider Proposed Merger With Watson Pharmaceuticals, Inc.
Royce Laboratories, Inc. Announces 1996 Record Year-End Results

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters